Compounds > n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine
Page last updated: 2024-09-03

n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and fluorouracil

n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine has been researched along with fluorouracil in 1 studies

Compound Research Comparison

Studies
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)		Trials
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)		Recent Studies (post-2010)
(n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine)		Studies
(fluorouracil)		Trials
(fluorouracil)		Recent Studies (post-2010) (fluorouracil)
140045,5629,30714,663

Protein Interaction Comparison

ProteinTaxonomyn(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine (IC50)fluorouracil (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.32
Thymidylate synthaseMus musculus (house mouse)1.58
AromataseHomo sapiens (human)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butash, KA; Casero, RA; Davidson, NE; Deveraux, WL; Dunn, VR; Hahm, HA; Woster, PM1

Other Studies

1 other study(ies) available for n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and fluorouracil

ArticleYear
Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Doxorubicin; Drug Synergism; Female; Fluorouracil; Humans; Paclitaxel; Polyamines; Tumor Cells, Cultured; Vinblastine; Vinorelbine

2001